BEN-9160

N/A

Report date: 2022/10/11 11:06:35
NME

Base Information

Drug NameBEN-9160
Drug Alias NameBEN-9160BEN9160
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionABL proto-oncogene 1 inhibitors
TargetsABL proto-oncogene 1
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBenevolentai Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBenevolentai Bio Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A